A clinical study to evaluate the efficacy of paste of Unani formulation with Paraffin wax therapy in the management of Non specific Low Back Pain

A comparative clinical study to evaluate the efficacy of Zimad of Unani formulation with Paraffin wax therapy in the management of Waja-Uz-Zahar (Non specific Low Back Pain) - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/08/072513

Enrollment

Registered

2024-08-14

Start date

Unknown

Completion date

Unknown

Last updated

2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M959- Acquired deformity of musculoskeletal system, unspecified Health Condition 2: M958- Other specified acquired deformities of musculoskeletal system

Interventions

Intervention1: Paste(Zimad): Site: Lumbosacral region. Patients of group-A will be treated with Zimad will be applied over the back of lumbosacral region manually and left therefore over night on alte

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of low back pain as a primary complaint for more than 12 weeks. 2. No radiation of low back pain to other region. 3. Clinically and radiologically diagnosed patients of Waja-uz-zahar (Non specific low back pain) 4. Patients who agreed to sign the informed consent and follow the protocol. 5. No allergy to Hulba, Katan, Roghan-e-babuna. 6. No apparent spine deformity like kyphosis, scoliosis, lordosis etc. 7. Willingness to participate in the study.

Exclusion criteria

Exclusion criteria: 1. Patients below the age 18 years and above 50 years. 2. Any systemic illness such as Liver, Kidney, Cardiac disorders, Diabetes mellitus, Hypertension, Osteomylitis, Tuberculosis. 3. Spinal deformity (Congenital / Acquired), Paget’s disease, Pot’s spine, Spinal tumor and Cancer. 4. Previous history of Trauma, Fracture or Surgery of lumbosacral region. 5. Having evidence of infection on the skin over the lumbosacral region. 6. On contraceptive / Steroid and Analgesic therapy. 7. Patients who do not report for follow up and who refuses to join the study. 8. Pregnant women. 9. A systemic or local allergic reaction to Hulba, Katan, Kunjud and Babuna. 10. Impaired sensation. 11. Implantation of prosthesis.

Design outcomes

Primary

Measure	Time frame
? VAS (Visual Analogue Scale) ? Oswestry low back pain disability questionnaire. Timepoint: 0, 7th, 14th, 21st and 28th day.	—

Secondary

Measure	Time frame
VAS (Visual Analogue Scale) Timepoint: 0 & 28th day.	—

Countries

India

Contacts

Public ContactAnish Ahamad Ansari

State Unani Medical College and Hospital, Himmatganj, Prayagraj, Uttar Pradesh (211016)

drbushraaftab@gmail.com8279747882

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026